Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maleska, Aleksandra"'
Autor:
Telser, Julia, Grossmann, Kirsten, Weideli, Ornella C, Hillmann, Dorothea, Aeschbacher, Stefanie, Wohlwend, Niklas, Velez, Laura, Kuhle, Jens, Maleska, Aleksandra, Benkert, Pascal, Risch, Corina, Conen, David, Risch, Martin, Risch, Lorenz
Publikováno v:
Telser, Julia; Grossmann, Kirsten; Weideli, Ornella C; Hillmann, Dorothea; Aeschbacher, Stefanie; Wohlwend, Niklas; Velez, Laura; Kuhle, Jens; Maleska, Aleksandra; Benkert, Pascal; Risch, Corina; Conen, David; Risch, Martin; Risch, Lorenz (2023). Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID-Results from the Prospective Population-Based COVI-GAPP Study. Diagnostics, 13(13) MDPI 10.3390/diagnostics13132167
It is unknown whether neurological symptoms are associated with brain injury after SARS-CoV-2 infections and whether brain injury and related symptoms also emerge in Long-COVID patients. Biomarkers such as serum neurofilament light chain (sNfL) and g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148c6ef0030db0f3046f4145fb9ed90a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Le, Ngoc Dung, Steinfort, Marel, Grandgirard, Denis, Maleska, Aleksandra, Leppert, David, Kuhle, Jens, Leib, Stephen L
Publikováno v:
Le, Ngoc Dung; Steinfort, Marel; Grandgirard, Denis; Maleska, Aleksandra; Leppert, David; Kuhle, Jens; Leib, Stephen L (2022). The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis. Scientific reports, 12(1), p. 12945. Springer Nature 10.1038/s41598-022-17282-0
One-third of pneumococcal meningitis (PM) survivors suffer from neurological sequelae including learning disabilities and hearing loss due to excessive neuroinflammation. There is a lack of efficacious compounds for adjuvant therapy to control this l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f2508a9f14b32a13efaa8c98abe0fc9
https://boris.unibe.ch/171661/1/s41598-022-17282-0__1_.pdf
https://boris.unibe.ch/171661/1/s41598-022-17282-0__1_.pdf
Autor:
Menjot De Champfleur, Nicolas, Maleska, Aleksandra, Marelli, Cecilia, Hourregue, Claire, Gutierrez, Laure-Anne, Paquet, Claire, Menjot de Champfleur, Nicolas, de Verbizier, Delphine, Jacob, Melissa, Dubois, Jonathan, Maleska, Aleksandra Maceski, Hirtz, Christophe, Navucet, Sophie, Bennys, Karim, Dumurgier, Julien, Cognat, Emmanuel, Berr, Claudine, Magnin, Eloi, Lehmann, Sylvain, Gabelle, Audrey
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, IOS Press, 2020, pp.1-9. ⟨10.3233/JAD-190378⟩
Journal of Alzheimer's Disease, IOS Press, 2020, pp.1-9. ⟨10.3233/JAD-190378⟩
International audience; : Background:Memory troubles and hippocampal atrophy are considered more frequent and focal atrophy less severe in late-onset (>65 years) than in presenile behavioral variant frontotemporal dementia (bvFTD). Objective:To compa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Telser J; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Dr. Risch Medical Laboratory, 9470 Buchs, Switzerland.; Faculty of Medical Sciences, Private University in the Principality of Liechtenstein (UFL), 9495 Triesen, Liechtenstein., Grossmann K; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Faculty of Medical Sciences, Private University in the Principality of Liechtenstein (UFL), 9495 Triesen, Liechtenstein., Weideli OC; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Soneva Fushi, Boduthakurufaanu Magu, Male 20077, Maldives., Hillmann D; Dr. Risch Medical Laboratory, 9470 Buchs, Switzerland., Aeschbacher S; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Department of Cardiology, University Hospital of Basel, 4031 Basel, Switzerland., Wohlwend N; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Faculty of Medicine, University of Bern, 3012 Bern, Switzerland., Velez L; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; University of St. Gallen, 9000 St. Gallen, Switzerland., Kuhle J; Neurologic Clinic and Policlinic, MS Center and Research Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, 4031 Basel, Switzerland., Maleska A; Neurologic Clinic and Policlinic, MS Center and Research Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, 4031 Basel, Switzerland., Benkert P; Neurologic Clinic and Policlinic, MS Center and Research Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, 4031 Basel, Switzerland., Risch C; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Dr. Risch Medical Laboratory, 9470 Buchs, Switzerland., Conen D; Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada., Risch M; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Dr. Risch Medical Laboratory, 9470 Buchs, Switzerland.; Division of Laboratory Medicine, Kantonsspital Graubünden, 7000 Chur, Switzerland., Risch L; Dr. Risch Medical Laboratory, 9490 Vaduz, Liechtenstein.; Dr. Risch Medical Laboratory, 9470 Buchs, Switzerland.; Faculty of Medical Sciences, Private University in the Principality of Liechtenstein (UFL), 9495 Triesen, Liechtenstein.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jun 26; Vol. 13 (13). Date of Electronic Publication: 2023 Jun 26.
Autor:
Le ND; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland., Steinfort M; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland., Grandgirard D; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland., Maleska A; Multiple Sclerosis Centre, Neurology, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, Switzerland., Leppert D; Multiple Sclerosis Centre, Neurology, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, Switzerland., Kuhle J; Multiple Sclerosis Centre, Neurology, Departments of Head, Spine and Neuromedicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.; Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), University Hospital and University of Basel, Basel, Switzerland., Leib SL; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland. stephen.leib@ifik.unibe.ch.
Publikováno v:
Scientific reports [Sci Rep] 2022 Jul 28; Vol. 12 (1), pp. 12945. Date of Electronic Publication: 2022 Jul 28.